Celecoxib (Celebrex) in the Management of Acute Renal Colic

Summary

The purpose of this trial is to quantify the amount Celebrex, a specific cyclooxygenase-2 (COX-2) inhibitor, when used for the management of acute renal colic for a ureteral stone will: * reduce pain medication usage * improve the percentage of spontaneous stone passage * decrease the time to spontaneous passage, and * shift the size distribution of stones passed towards larger sizes

Timeline

Start

2006-03

Primary completion

2008-08

Completion

2008-08

Drugs

Indications